Quarterly report [Sections 13 or 15(d)]

Business Combination - Pro Forma Information (Details)

v3.25.2
Business Combination - Pro Forma Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Pharmagesic    
Business Combination    
Net loss before taxes $ (2,451,151) $ (5,163,258)